FDA’s Rejection of MDMA Psychotherapy for Trauma Draws Criticism from Psychedelic Experts
Many experts criticize the FDA’s recent negative ruling on MDMA therapy for PTSD, saying the agency ignored solid overall results from clinical trials
Read More from the Global Wellness News ™